C. R. Bard Inc. is an American multinational developer, manufacturer, and marketer of medical equipment. It is a global leader in the medical device industry.
The company is headquartered in Murray Hill, New Jersey, USA, with a total of around 13,000 employees.
It focuses on products in the following fields: Vascular, Urology, Oncology, and Surgical Specialty.
It provides its services through four primary divisions: Bard Access Systems, Inc., Bard Medical Division, Davol Inc., and Bard Peripheral Vascular, Inc.
Charles R. Bard founded the company in New York City in 1907. His business originally focused on selling Gomenol – a treatment option for urinary discomfort. The company was incorporated in 1923.
Bard went public in 1963 and was later listed on the New York Stock Exchange under the stock ticker symbol ‘BCR’.
The company is well known for having introduced the Foley catheter (a tube that passes through the urethra and into the bladder) in 1934.
Bard’s vision is to “advance the delivery of Healthcare by profitably developing, manufacturing and marketing value-driven products which meet the quality, integrity, service, and innovation expectations of our customers while providing opportunities for our employees.”
C. R. Bard Inc. – Company Overview
- Chairman and CEO: Timothy M. Ring
- Industry: Medical Devices
- Type: Public
- Listed on the New York Stock Exchange (NYSE)
- NYSE stock symbol: BCR
- S&P 500 Component
- Founded: 1907
- Founder: Charles Russell Bard
- Net sales: $3.049 billion USD (2013)
- Net income: $689 million USD (2013)
- Diluted earnings per share: $8.39 USD (2013)
- Employees: 13,000 (2013)
- Company head office: 730 Central Avenue, Murray Hill, New Jersey 07974, USA
- Corporate contact number: (908) 277-8000
- Website: http://www.crbard.com/
C. R. Bard Inc. – Financial Results
|Income statement data (in $ millions)||2013||2012|
|Total costs and expenses||$1,836.1||$2,225.7|
|Income from operations before income taxes||$1,213.4||$732.4|
|Income tax provision||$523.6||$202.3|
|Balance sheet data (in $ millions)|
|Total shareholders’ investment||$2,088.2||$1,925.7|
|Common share data (in $)|
|Earnings per Common Share – Basic||$8.54||$6.24|
|Earnings per Common Share – Diluted||$8.39||$6.16|
Source: “C. R. Bard, Inc. 2013 Form 10-K”
C. R. Bard Inc. – Live Stock Market Data